-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Aytu Biopharma, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2023.
- Aytu Biopharma, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$6.62M, a 698% decline year-over-year.
- Aytu Biopharma, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$7.71M, a 424% decline year-over-year.
- Aytu Biopharma, Inc annual Nonoperating Income (Expense) for 2023 was $14K, a 98.6% decline from 2022.
- Aytu Biopharma, Inc annual Nonoperating Income (Expense) for 2022 was $1.02M, a 21.1% increase from 2021.
- Aytu Biopharma, Inc annual Nonoperating Income (Expense) for 2021 was $840K, a 88.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)